Skip to main content
Top

Concomitant IgA nephropathy and dermatomyositis: a case-based review

Published in:

Abstract

IgA nephropathy concomitant with dermatomyositis is extremely rare. We describe a 38-year-old male who presented with generalized swelling and scanty red urine followed by proximal muscle weakness and dysphagia. Urinalysis revealed proteinuria, hematuria, and red blood cell casts. Renal biopsy showed IgA deposition in the mesangial tissue of the glomerulus by immunofluorescence technique, compatible with IgA nephropathy. He had no preceding history of respiratory tract infections or associated illnesses like inflammatory bowel disease, ankylosing spondylitis, psoriasis, cirrhosis or IgA vasculitis. The patient was treated with prednisolone and mycophenolate mofetil and within 12 weeks nephropathy and muscle weakness improved, as well as the skin rash. We review the existing literature regarding the concurrence of dermatomyositis and IgA nephropathy. The combination of these disorders in adult patients appears to be extremely rare, to our knowledge this is the third published case. In children there have been published another 3 cases. Although we cannot exclude a co-incidence that two disorders are found in the same patient, it seems more likely that a common pathological mechanism plays a role.
Title
Concomitant IgA nephropathy and dermatomyositis: a case-based review
Authors
Md. Gias Uddin
Md. Nazrul Islam
Kassim Hagi Hussain
Johannes J. Rasker
Publication date
19-12-2025
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 1/2026
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-025-06038-4
This content is only visible if you are logged in and have the appropriate permissions.

Keynote webinar | Spotlight on advances in lupus

Systemic lupus erythematosus is a severe autoimmune disease that can cause damage to almost every system of the body. Learn more about novel biomarkers for diagnosis and monitoring, and familiarize yourself with current and emerging targeted therapies.

Prof. Edward Vital
Prof. Ronald F. van Vollenhoven
Watch now
Video

Elevate your expertise in aplastic anemia (Link opens in a new window)

Transform the way you care for your patients with aplastic anemia with our 3-module series using real-world case studies and expert insights. Discover why early diagnosis matters, explore the benefits and risks of current treatments, and develop tailored approaches for complex cases. 

Supported by:
  • Pfizer
Developed by: Springer Health+ IME
Learn more
Image Credits
Hand of patient with IgA nephropathy and dermatomyositis/© 2025, Md. Gias Uddin et al, under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature, Lupus concept/© (M) Vitalii But / stock.adobe.com / Generated with AI, Aplastic Anemia/© Springer Healthcare IME